Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Urinary tract infections (UTIs) are a common public health problem, mainly caused by uropathogenic (UPEC). Patients with chronic UTIs are usually treated with long-acting prophylactic antibiotics, which promotes the development of antibiotic-resistant UPEC strains and may complicate their long-term management. D-mannose and extracts rich in D-mannose such as mannan oligosaccharides (MOS; D-mannose oligomers) are promising alternatives to antibiotic prophylaxis due to their ability to inhibit bacterial adhesion to urothelial cells and, therefore, infection. This highlights the therapeutic potential and commercial value of using them as health supplements. Studies on the effect of MOS in UTIs are, however, scarce. Aiming to evaluate the potential benefits of using MOS extracts in UTIs prophylaxis, their ability to inhibit the adhesion of UPEC to urothelial cells and its mechanism of action were assessed. Additionally, the expression levels of the pro-inflammatory marker interleukin 6 (IL-6) were also evaluated. After characterizing their cytotoxic profiles, the preliminary results indicated that MOS extracts have potential to be used for the handling of UTIs and demonstrated that the mechanism through which they inhibit bacterial adhesion is through the competitive inhibition of FimH adhesins through the action of mannose, validated by a bacterial growth impact assessment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384913 | PMC |
| http://dx.doi.org/10.3390/pathogens12070885 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fishing out AIEC with FimH capturing microgels for inflammatory bowel disease treatment.
Nat Commun
August 2025
Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, P. R. China. guo
Inflammatory bowel disease (IBD) is a chronic immune-mediated condition with rising global incidence and limited treatment options. Current therapies often have poor efficacy and undesirable side effects. Here we present a drug-free strategy that targets bacterial adhesion to manage IBD.
View Article and Find Full Text PDFVancomycin-sensitive gut microbiota mediate Dendrobii β-1,4-mannan degradation and anti-colitis activity in mice.
Int J Biol Macromol
August 2025
School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. Electronic address:
While Dendrobii β-1,4-mannan (DOP) shows promise in treating colitis, previous research only correlated changes in gut microbiota composition with DOP's effects, without elucidating the specific mechanism by which gut microbiota mediates DOP's bioactivities. This study addresses this crucial gap by demonstrating the essential role of vancomycin-sensitive gut bacteria in mediating the anti-colitis effects of DOP. Using targeted antibiotic perturbation, we found that vancomycin, but not neomycin, abolished both DOP degradation and its therapeutic effects in colitis mice.
View Article and Find Full Text PDFIndividual and Combined Effect of Zinc-L-Selenomethionine Complex with Mannan-Oligosaccharide on Growth Performance, Carcass Characteristics, Gut Development and Immune Response in Broilers.
Vet Sci
August 2025
Department of Animal Production, College of Food and Agriculture Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.
Due to the increased restrictions on antibiotic growth promoters (AGPs), natural substitutes such as organic selenium and prebiotics are gaining increased attention to enhance the gut health and performance of broilers. This study aimed at assessing the effects of organic selenium separately and in combination with mannan-oligosaccharides (MOSs) on gut development, immunity, carcass traits and overall growth performance in broiler chickens. For this study, 528-day-old straight-run broiler chicks (Ross-308) were assigned to four dietary treatments (six replicates of 22 birds each), in a completely randomized design under a 2 × 2 factorial layout, including: (1) Se0.
View Article and Find Full Text PDFEffects of Mannan Oligosaccharides on Growth, Antioxidant and Immune Performance, and mTOR Signaling Pathway in Juvenile Tilapia ().
Animals (Basel)
August 2025
Guangxi Academy of Marine Sciences, Guangxi Institute of Oceanology Co., Ltd., 92 Changqingdong Road, Beihai 536000, China.
Mannan oligosaccharide (MOS), a prebiotic derived from yeast cell walls, has been shown to enhance growth performance and health status in various aquatic species. As an exogenous antigen adjuvant, MOS modulates T-cell-mediated immune responses, thereby improving immune function and suppressing excessive inflammatory reactions. This study aimed to evaluate the effects of dietary MOS supplementation on growth performance, serum biochemical parameters, muscle composition, digestive enzyme activity, antioxidant and immune status, and the mTOR signaling pathway in juvenile GIFT tilapia ().
View Article and Find Full Text PDFTargeting dendritic cell-specific TNFR2 improves skin and joint inflammation in a murine model of psoriatic arthritis.
Sci Rep
August 2025
Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, USA.
Psoriasis (PsO) and Psoriatic arthritis (PsA) are TNF-alpha-dependent immune-mediated inflammatory diseases where dendritic cells (DC) play a critical role in disease pathogenesis. Although TNF-alpha receptor 2 (TNFR2) has been implicated in the pathology of psoriatic diseases, its specific role in DC mediated responses remains unclear. To investigate the role of TNFR2 in DC in psoriatic disease, we utilized the mannan-oligosaccharide (MOS) model of PsA on mice with either TNFR2 intact or with DC-specific TNFR2 knockout (DC-TNFR2KO).
View Article and Find Full Text PDF